A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

"Alzheimer's is a progressive neurodegenerative ... affecting myelin—an insulating layer that lines the outside of our nerve cells—production and subsequently disrupting neural communication.

The human brain is a complex powerhouse, responsible for orchestrating thoughts, emotions, and memories. Its nerve cells require an immense amount of energy to function. This energy is critical for ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers cellular inflammation and aging and is linked to Alzheimer's disease, ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

6, 2025 — A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein ... have shown that specialized cells involved in how the body responds to insulin ...

shows the potential of inhaled xenon to activate the brain’s immune cells, called microglia, to break down plaques that are a hallmark of Alzheimer’s as well as reduce inflammation in the brain.

Scientists provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer's disease. Their findings, based on studies in cell culture, mice and tissue ...